Sign In
Buy GHRS
$23.61
+1.52 (+6.88%)
At Close: Jun 23, 2026
7 Short-Squeeze Stocks for Bold Contrarians to Consider
12:22pm, Monday, 21'st Nov 2022
Throughout much of the new normal, the concept of short-squeeze stocks took off like wildfire. Essentially, this tactic centers on taking a contrarian bet against bearish traders in Wall Street's vers
New Strong Buy Stocks for October 24th
09:02am, Monday, 24'th Oct 2022
BXRX, WOLF, GHRS, RKDA and BHR have been added to the Zacks Rank #1 (Strong Buy) List on October 24, 2022.
Wall Street Analysts See a 262% Upside in GH Research PLC (GHRS): Can the Stock Really Move This High?
11:13am, Wednesday, 14'th Sep 2022
The consensus price target hints at a 262% upside potential for GH Research PLC (GHRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es
7 Psychedelics Stocks to Buy for a Big Drug Boom
03:02pm, Tuesday, 30'th Aug 2022
Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts a
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
04:31pm, Wednesday, 19'th Jan 2022
Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.53% at $5.58
GH Research Stock (GHRS): Why The Price Jumped Today
05:38pm, Monday, 06'th Dec 2021
The stock price of GH Research PLC (NASDAQ: GHRS) increased by 21.86% today. This is why it happened.
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
02:16pm, Monday, 06'th Dec 2021
Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ: GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy candidate for patients suffer
GH Research Posts Data From Treatment-Resistant Depression Trial
10:15am, Monday, 06'th Dec 2021
GH Research PLC (NASDAQ: GHRS) has reported the outcome of the Phase 2 part of a Phase 1/2 trial of GH001, an inhalable 5-MeO-DMT product candidate for treatment-resistant depression (TRD). The tri
9 Psychedelic Stocks to Watch For 2022
08:00am, Monday, 06'th Dec 2021
The usage of psychedelics like psilocybin, LSD, ketamine, and others are becoming more mainstream, especially with the initial steps to legalization getting moving across a number of states in the U.S
GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results
05:25pm, Thursday, 23'rd Sep 2021
DUBLIN, Ireland, Sept. 23, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological d
GH Research: A Recent IPO Stock That Could Possibly Be A Trailblazer In A Hot Industry
03:55am, Sunday, 15'th Aug 2021
The WHO predicts that depression will be the biggest problem in the world during the next decade and beyond. GH Research had a rather successful IPO on the 24th of June.
7 Companies Go Public Today. What Investors Need to Know.
01:23pm, Friday, 25'th Jun 2021
Acurx Pharmaceuticals, Alpha Teknova, Elevation Oncology, GH Research, Graphite Bio, and MissFresh are listed on the Nasdaq. Mister Car Wash is trading the New York Stock Exchange.
GH Research Seeks $125 Million IPO
08:25pm, Tuesday, 22'nd Jun 2021
GH Research has filed proposed terms for a $125 million U.S. IPO. The firm is developing treatments for treatment resistant depression and other neurological conditions.
